WORLD HEALTH ORGANIZATION
Clinical Trials
107
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (90 trials with phase data)• Click on a phase to view related trials
Impact of Alcohol Labels in a Real-World Setting
- Conditions
- KnowledgeBehaviour ChangeRisk PerceptionIntentionSupport for Alcohol PoliciesEmotional ResponseProduct Appeal
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- World Health Organization
- Target Recruit Count
- 1300
- Registration Number
- NCT06915298
- Locations
- 🇪🇸
Sampled supermarkets in selected city neighbourhoods, Barcelona, Spain
An Adolescent Health and Wellbeing Check-up Programme in Three African Cities (Y-Check)
- Conditions
- Health Care Seeking BehaviorAdolescent BehaviorHealth-Related BehaviorAdolescent Development
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- World Health Organization
- Target Recruit Count
- 6000
- Registration Number
- NCT06090006
- Locations
- 🇬🇭
Schools and Community Centers, Cape Coast, Ghana
🇿🇼Schools and community centers, Chitungwiza, Zimbabwe
Strengthening Contraceptive Counseling Services: Research Protocol for a Multi-phase Complex Intervention in Pakistan and Nigeria
- Conditions
- EmpowermentContraceptionDecision Making
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2023-10-13
- Lead Sponsor
- World Health Organization
- Target Recruit Count
- 7920
- Registration Number
- NCT06081842
Empowering Adolescents to Lead Change Using Health Data
- Conditions
- Healthy
- First Posted Date
- 2021-07-15
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- World Health Organization
- Target Recruit Count
- 12612
- Registration Number
- NCT04963426
- Locations
- 🇨🇭
WHO, Geneva, Switzerland
Malaria Vaccine Pilot Evaluation
- Conditions
- SafetyMalaria,FalciparumFeasibilityMortality
- First Posted Date
- 2019-01-16
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Rafiq OKINE
- Target Recruit Count
- 30124
- Registration Number
- NCT03806465
- Locations
- 🇬🇭
Kintampo Health Research Centre, Kintampo, Ghana
🇰🇪CDC Kenya Malaria Programme, Kisumu, Kenya
🇲🇼College of Medicine, Blantyre, Malawi
- Prev
- 1
- 2
- Next
News
WHO Includes ArkBio's Ziresovir in Pediatric RSV Drug Priority List, Marking First Chinese Anti-RSV Drug Recognition
The World Health Organization has included ziresovir (10mg) from Shanghai Ark Biopharmaceutical in its PADO-RSV priority list, making it the first and only RSV antiviral drug selected for the program.
ViiV Healthcare Expands Generic License for Long-Acting HIV Treatment to 133 Countries
ViiV Healthcare has expanded its voluntary licensing agreement with the Medicines Patent Pool to allow generic production of cabotegravir for HIV treatment in 133 countries, including all low-income and Sub-Saharan African nations.
Nontargeted HCV Screening in Emergency Departments Identifies 34% More New Infections Than Risk-Based Approach
The DETECT Hep C Trial, the largest pragmatic clinical trial of HCV screening in emergency departments to date, found that nontargeted screening identified significantly more new hepatitis C infections than targeted screening (relative risk 1.34, P=0.02).
Two New Tuberculosis Drugs Show Superior Safety Profile Over Linezolid in Phase 2b Trials
Two Phase 2b clinical trials led by LMU University Hospital Munich demonstrated that sutezolid and delpazolid, both oxazolidinone antibiotics, offer safer alternatives to linezolid for tuberculosis treatment with no cases of nerve damage or blood toxicity observed.
India Launches First Indigenous Dengue Vaccine Phase 3 Trial with Over 10,000 Participants
The Indian Council of Medical Research (ICMR) and Panacea Biotec have initiated India's first Phase 3 clinical trial for an indigenous tetravalent dengue vaccine called DengiAll.
Bharat Biotech and GSK Pledge to Cut Malaria Vaccine Price by More Than Half to Under $5 by 2028
Bharat Biotech and GSK announced they will reduce the price of the world's first malaria vaccine RTS,S by more than half to less than $5 per dose by 2028.
Trinity Biotech Receives WHO Approval for Offshore Manufacturing of HIV Rapid Test
Trinity Biotech received World Health Organization approval for offshored and outsourced upstream manufacturing of its TrinScreen HIV rapid test, marking a critical milestone in the company's transformation plan.
Favipiravir Shows Promise Against Deadly Chandipura Virus in Preclinical Studies
The antiviral drug Favipiravir demonstrated substantial protection against Chandipura virus in preclinical studies conducted by India's National Institute of Virology.
CanSinoBIO Launches iPneucia® 13-Valent Pneumococcal Vaccine Optimized for Chinese Children
CanSino Biologics has launched iPneucia®, a 13-valent pneumococcal conjugate vaccine specifically optimized for China's local pneumococcal epidemiology to protect Chinese children.
Dupilumab Treatment for Atopic Dermatitis Linked to Increased Psoriasis Risk in Large-Scale Study
A large retrospective cohort study of 19,720 patients found that dupilumab treatment for atopic dermatitis was associated with a 58% increased risk of developing psoriasis compared to other systemic therapies.